This inventor holds 1 USPTO granted patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Weijian Qin: Innovator in Gene Nomenclature Standardization
Introduction
Weijian Qin is a notable inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of medical text processing, particularly in the standardization of gene nomenclature. His innovative approach addresses the complexities of gene name normalization, which is crucial for accurate medical data interpretation.
Latest Patents
Weijian Qin holds a patent titled "Method and system for normalization of gene names in medical text." This patent outlines a comprehensive method for standardizing gene nomenclature. The process involves several steps, including receiving a source, tokenizing it, and comparing tokens to a prefix tree structure. The method ensures that gene names are accurately identified and standardized, enhancing the reliability of medical texts.
Career Highlights
Weijian Qin is associated with Koninklijke Philips Corporation N.V., where he applies his expertise in medical technology and data processing. His work at Philips highlights his commitment to advancing healthcare through innovative solutions. With a focus on improving medical text analysis, Qin's contributions are vital in the ongoing evolution of medical informatics.
Collaborations
Weijian has collaborated with talented colleagues such as Yong Mao and Qingxin Wu. Their combined efforts in research and development have fostered an environment of innovation and creativity within their projects.
Conclusion
Weijian Qin's work in gene nomenclature standardization exemplifies the impact of innovation in the medical field. His patent and contributions to Koninklijke Philips Corporation N.V. reflect a dedication to improving healthcare through technology.